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Introduction: Juvenile granulosa cell tumor (JGCT) is a subtype of granulosa cell tumors of the ovary. 80% of 
JGCT occurs at prepubertal period. And, it is considered to be a slow growing tumor. In addition, gross 
appearence of it is mostly solid. Herein, we report a pure cystic JGCT case that was detected soon after childbirth 
with huge dimension. 
Presentation of Case: We report a 21 year-old woman who presented with abdominal mass during 6th month 
after childbirth. Ultrasound revealed a cystic mass of approximately 20 cm in diameter originated from left 
ovary. The patient underwent laparotomy and unruptured left ovari an cystic mass resection was performed. 
Uterus and right ovary were totally normal and extraovarian spread was not found. Macroscopic examination 
revealed totally cystic tumor of 25,5x22x10,2 cm with smooth outlines, containing serous fluid. There were 
papillary projections and small polypoid structures around 1 cm in diameter into the cavity. Histopathologic and 
immunohistochemical findings were compatible with JGCT. Relaparotomy was performed for staging and the 
patient was evaluated as stage IA. She is currently under clinical follow up without any further treatment.  
Conclusion: It should be noted that JGCT may rapidly grow and reach a higher dimension, occur during 
pregnancy and at postpartum period, and may present as cystic rather than a solid mass as in our case presented 
here.  
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Introduction 
Granulosa cell tumors are rare tumors that comprise 
1-2% of all ovarian malignancies [1]. Two subtypes 
as adult and juvenile granulosa cell tumors exist 
according to their different clinical, histopathological 
and prognostic features [1]. Juvenile granulosa cell 
tumor accounts for 5-15% of granulosa cell tumors 
[2]. Approximately 80% of JGCT occurs during the 
prepubertal period (mean: 13 year-old) [3]. At this 
period the presenting symptoms are breast 
development, appearance of axillary and pubic hair 
referring to isosexual pseudoprecocity [3]. 
Postpubertal patients can present with abdominal 
pain and swelling, irregular menstruel bleeding or 
acute abdominal symptoms [2]. Ten percent of 
granulosa cell tumors are reported to present during 
pregnancy [3]. There are limited data about ovarian 
neoplasms including JGCT associated with 
pregnancy in the literature [3-7]. The incidence of 
ovarian malignancy detected during pregnancy is 
estimated to range from 1/76 to 1/2328 deliveries [7]. 
The percentage of malignant tumors ranges from 
2.15% to 13.5% of the adnexal masses detected 
during pregnancy [7]. The most common malignant 
tumors associated with pregnancy are epithelial 
tumors (33-65%), germ cell tumors (17-40.9%), 
sex-cord stromal tumors (9.1-20%), and other tumors 
(0-13%) may also be seen [8]. 
The gross features of JGCT are usually similar to 
adult type. Therefore, generally the neoplasm is 
composed of both solid and cystic areas (49%). Pure 
solid (37%) or pure cystic (14%) JGCTs are also on 
record [9]. Herein, we report a cystic JGCT that was 
detected soon after childbirth that no mass or 
symptom was observed during pregnancy in a 
21-year-old woman. 
Case Report 
A 21 year-old woman presented with abdominal 
mass after giving birth to her second child at 6th 
month was admitted to the Obstetrics-Gynecology 
Clinic. Ultrasound revealed a cystic mass of 
approximately 20 cm in diameter originated from 
left ovary. The history of the patient was uneventful 
including the follow up of her pregnancy. CA-125 
level was 55 IU/ml (Normal: < 35 IU/ml). The 
patient underwent laparotomy and unruptured left 
ovarian cystic mass resection was performed. 
Uterus and right ovary were totally normal and 
extraovarian spread was not found. Macroscopic 
examination revealed totally a cystic tumor of 25, 
5x22x10,2 cm with smooth outlines, containing 
serous fluid (Figure 1a). There were papillary 
projections and small polypoid structures around 1 
cm in diameter into the cavity (Figure 1b). Besides, 
cystic cavity with hemorrhagic fluid of 2,5x2,2x1,2 
cm was encountered (Figure 1b). Histologic 
sections disclosed solid cellular pattern of tumor 
protruding to the cavity and localized in the cyst 
wall (Figure 1c). Tumor cells were oval or round 
shaped, having hyperchromatic nucleus with 
minimal atypia and eosinophilic cytoplasm. Tumor 
cells have lacked nuclear grooves (Figure 1d). 
Mitotic activity was high, ranging between 
15-20/10 high power fields (HPF) (Figure 1d). The 
stroma was loose or myxoid, or showed 
fibrothecomatous characteristics. Tumor also 
consisted of luteinized cells (Figure 1e), and round, 
oval or irregular shaped follicles containing pale 
eosinophilic secretion (Figure 1f). Tumor was 
restricted to the cyst wall. The tumor cells showed 
cytoplasmic and dot-like immunostaining with 
pancytokeratin (Figure 2a). Tumor cells have been 
strongly stained by vimentin, CD99, CD56. 
Nuclear and cytoplasmic immunoreactivity was 
seen by calretinin. Inhibin positivity was 
encountered especially in luteinized cells (Figure 
2b). Weak staining was observed by EMA. 
Chromogranin, synaptophysin and AFP were 
negative. Histopathologic and 
immunohistochemical findings were compatible 
with juvenile granulosa cell tumor. Relaparotomy 
was performed for staging and the patient was 
evaluated as stage IA. The patient was under 
clinical follow up for 7 months with uneventful 
clinical course and has not received any further 
treatment. 
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Figure 1 a. The macroscopic photograph of the cystic lesion with smooth outlines. b. The macroscopic photograph of the 
inner surface of the lesion. c. The microscopic photograph showing cyst wall and the solid tumor component protruding 
to the cavity, (Hematoxylin and eosin stain, original magnification, x40). d. Photomicrograph of the tumor cells with 
eosinophilic cytoplasm and hyperchromatic nucleus that lack nuclear grooves and show numerous mitoses (arrows), 
(Hematoxylin and eosin stain, original magnification, x400). e. Photomicrograph of the tumor containing numerous 
luteinized cells that have vacuolised clear cytoplasm, (Hematoxylin and eosin stain, original magnification, x400). f. 
Photomicrograph of the round, oval or irregular shaped follicles-the cystic spaces containing pale eosinophilic secretion, 
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Figure 2 a. Characteristic dot-like immunostaining with pancytokeratin in the tumor cells, (Avidin-biotin-peroxidase 
method, original magnification, x200). b. Immunopositivity with inhibin in the tumor cells especially in the luteinized 
cells, (Avidin-biotin-peroxidase method, original magnification, x200). 
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Discussion 
98% of JGCTs are unilateral [2]. Generally solid 
component predominates but it may contain cystic 
component at various degrees [2]. The diameter of 
the tumor ranges from 2, 5 cm to 32 cm [2]. As 
JGCTs can reach a huge size, intraoperative rupture 
can be seen in 10% of cases. Our patient presented 
with rapidly growing unilateral ovarian cystic mass 
at postpartum period; the unruptured tumor was 
excised totally. 
JGCT is histopathologically characterized by 
granulosa cell proliferation in diffuse or nodular 
fashion in myxoid or oedematous background [2]. 
Nodules may become totally hyalinised [2]. 
Follicular structures of various size and shape are 
encountered among the nodules or solid cellular 
areas [2]. However, Call Exner bodies are almost 
never present or may be very rarely seen [2, 10]. 
Tumor cells have abundant eosinophilic cytoplasm 
and round-oval hyperchromatic nuclei which lack 
nuclear groove that distinguish them from those of 
adult granulosa cell tumor [2, 10]. Severe nuclear 
atypia can be observed and mitotic rate is high 
(1-32/10 HPF) [2]. Scattered luteinized cells can be 
seen and they become numerous at pregnancy. 
Immunohistochemically tumor cells are usually 
positive with inhibin, calretinin, WT-1, CD 56, CD 
99, vimentin, S100 and SMA [2]. Dot-like 
cytoplasmic staining pattern by pancytokeratin as 
shown in our case is characteristic for granulosa 
cell tumors [10]. 25-50% of JGCTs may exhibit 
focal EMA positivity in contrast to other sex-cord 
stromal tumors. CK 7 and desmin are negative [2, 
10]. 
Differential diagnosis of JGCT from adult type 
granulosa cell tumor is important. Adult type 
granulosa cell tumors occur mostly in 
postmenapousal women although they may be seen 
at any age [2, 10]. The present case was 
differentiated from adult type granulosa cell tumor 
by diffuse cellular pattern of the tumor, presence of 
follicular structures, lack of Call Exner bodies, and 
presence of cells without nuclear grooves and high 
mitotic rate of tumor cells. Thecoma can be 
considered in differential diagnosis because of the 
presence of luteinized cells in JGCT but thecomas 
do not contain follicular structures or high mitotic 
rate [2]. Besides, the neoplastic cells are 
characteristically surrounded by reticulin fibers 
individually in thecoma [2, 10]. JGCT may be 
confused with yolk sac tumor. However, presence 
of Schiller-Duval bodies and accompanying other 
germ cell components, AFP positivity and inhibin 
negativity are of help in diagnosing the latter [2]. 
JGCT is sometimes misinterpreted as primary or 
metastatic malignant melanoma because of the 
histopathologic features and rare inhibin positivity 
of melanoma [2]. Immunopositivity with HMB-45 
and Melan-A, and the presence of melanin pigment 
are helpful in differential diagnosis [2]. As JGCT 
contains luteinized cells, it can be confused with 
clear cell carcinoma [2]. Clear cell carcinoma 
occurs in more elderly women. The 
immunohistochemical demonstration of EMA and 
CK 7 staining and inhibin negativity make the 
correct diagnosis possible [2]. Small cell carcinoma 
of hypercalcemic type may be considered in 
differential diagnosis of JGCT. It is seen in young 
women with aggresive course, showing follicle like 
structures composed of cells with hyperchromatic 
nuclei and high mitotic rate [2]. However, 
clinically JGCT is usually associated with 
estrogenic manifestations and small cell carcinoma 
exhibits hypercalcemia. Besides, the latter 
demonstrates inhibin negativity and growth pattern 
with solid sheets rather than nodules [2]. 
Adnexal masses during pregnancy is rare, there 
are some case reports and series in the literature [3-7]. 
The incidence of the adnexal masses has raised 
especially after the advent of ultrasound use during 
pregnancy. In 2011 Aggarwal et al. rewieved the 
literature (between January 1984–November 2009) 
about the ovarian tumors in pregnancy. According to 
this study the prevalance of the adnexal masses 
ranges from 1/76 to 1/2328 deliveries [7]. A higher 
prevalence of 1/19–1/88 has been recorded in the 
studies based purely on ultrasound detection of 
adnexal masses in pregnancy [7]. The percentage of 
malignant tumors, both low malignant potential and 
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ovarian cancer, ranges from 2.15% to 13.5% of the 
adnexal masses in pregnancy. Studies reporting only 
malignant ovarian tumors have shown an incidence 
of 0.073–0.11 cases per 1000 deliveries [7]. 
Ultrasound based studies have detected a lower 
incidence of malignancy, ranged from 0 to 3.6% [7]. 
Some features as solid areas, papillary projections 
and septations increase suspicion for malignancy on 
ultrasound. Tumor markers like CA-125 have a 
limited aid in differentiating benign from malignant 
tumors in pregnancy as levels increase during 
pregnancy, especially in the first trimester [7].  
The majority of the masses are detected in the first 
two trimesters (50-80%) of pregnancy. 8% of 
malignant ovary tumors are diagnosed in the first 
trimester, 7.3% are diagnosed in the second trimester, 
24.2% are diagnosed in the third trimester, and 
26.8% are diagnosed in postpartum period [7]. 
In general, 65-80% of the cases are asymptomatic. 
However, the patients with malignancy are more 
usually symptomatic of abdominal mass (> 50%), 
pain or constitutional symptoms, only 25% of the 
cases are asymptomatic. Torsion may occur in 3-28% 
of the patients [7]. 
The majority of adnexal masses in pregnancy is 
benign. Dermoid cyst (37-50%) is the most common 
lesion, cystadenoma (20-24%), endometrioma 
(5-11%), and functional cysts (6-13%) are also 
detected during pregnancy in a decreasing order of 
frequency [11-12].  
Primary epithelial malignancies (33-65%) of the 
ovary are reported to be the most common malignant 
tumors in pregnancy, followed by germ cell tumors 
(17-40.9%), sex-cord stromal tumors (9.1-20%), and 
other tumors (0-13%) [8]. Thirty one malignant 
ovarian tumours (3.2%) have been rewieved in 12 
studies composed of 944 cases with adnexal masses 
in pregnancy in the literature [7]. These cases 
included 8 serous cystadenocarcinomas, 5 mucinous 
cystadenocarcinomas, 4 unspecified epithelial 
cancers, 4 immature teratomas, 3 Brenner tumors, 3 
dysgerminomas, 2 juvenile granulosa cell tumors and 
1 embryonal cell carcinoma and 1 Sertoli-Leydig 
tumor. Zhao et al. have reported 2 cases of JGCT in 
pregnancy [8]. One of the cases with JGCT presented 
with abdominal mass and pain during pregnancy, the 
other case was asymptomatic and presented with 
adnexal mass detected during cesarean as our case. 
Also, no hyperestrogenemia or hyperandrogenemia 
sign has been observed in these cases similar to our 
case. But these signs should be considered that they 
might appear in sex-cord stromal tumors 
complicating pregnancy. Aybatlı et al. have reported 
a case of 19-year-old woman presented with 
abdominal ascite and a mass about 10 cm in diameter 
one year after term pregnancy [1]. Similar to this 
report our patient presented with a huge adnexal 
mass at 6th month of childbirth. This suggests that 
the tumor presumably was present during pregnancy 
or even before. Most probably it was not noticed 
because of the small size of the tumor initially or 
masking of growing uterus at ultrasound. It may also 
be possible that the tumor appeared after pregnancy 
and has grown rapidly without any relation with 
pregnancy. 
In general, JGCT is considered as a low malignant 
potential tumor but it has the risk of local extension 
and recurrences. Almost all the recurrences of JGCT 
appear within 3 postoperative years [2]. They are 
usually slow growing tumors but as in our present 
case, tumors rapidly reaching huge size can be 
encountered. The most important prognostic 
parameter is the stage of the tumor [2]. Most of the 
cases are diagnosed at early stages (90% of cases at 
FIGO stage I). The five-year survival rate is about 
95% in stage I and stage II tumors, about 59% in 
stage I and stage II tumors. It is reported that 
excision of the tumor is almost always curative for 
stage IA tumors. However the course of the late stage 
tumors can be mortal [2, 10]. It is suggested that the 
pregnancy does not modify the prognosis of JGCT 
[5]. There is no knowledge reported about the effect 
of pregnancy on the pathogenesis of JGCTs in the 
literature. It may be considered to be incidental. 
In general, the patients are young and the 
involvement is unilateral, the removal of the 
involved ovary and salphenx, and complete staging 
is the preferred surgical approach in order to 
preserve fertility [2]. Total abdominal histerectomy 
and bilateral salphingo-ooferectomy, and “debulking” 
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are performed for late stage patients. Chemotherapy 
may be indicated. 
Conclusion 
It is noteworthy that JGCT may rapidly grow and 
reach a higher dimension, occur during pregnancy 
and at postpartum period, and may present as cystic 
rather than a solid mass as in our case presented 
here.    
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